Today: 9 June 2026
CoreWeave stock slips after-hours after insider sale filing; CRWV traders watch what comes next
31 December 2025
1 min read

CoreWeave stock slips after-hours after insider sale filing; CRWV traders watch what comes next

NEW YORK, December 30, 2025, 17:53 ET — After-hours

  • CoreWeave (CRWV) closed down 1.36% at $73.90 and slipped to $73.70 in after-hours trade.
  • A filing showed Chief Strategy Officer Brian M. Venturo sold 281,250 shares worth about $22.3 million under a pre-arranged trading plan.
  • U.S. stocks finished slightly lower in thin year-end trade, with tech mixed as investors digested Fed minutes.

CoreWeave shares fell 1.4% to $73.90 in regular trading on Tuesday and slipped 0.3% after the bell to $73.70.

The stock move landed as investors weighed an insider sale disclosed in a regulatory filing, a headline that can carry extra weight in holiday-thin markets when volumes are light and price swings can widen.

CoreWeave has become a closely watched proxy for artificial-intelligence infrastructure spending, and traders remain quick to react to signs of added share supply or shifts in sentiment around capital intensity.

In a Form 4 filed on Monday, Chief Strategy Officer and director Brian M. Venturo reported selling 281,250 Class A shares on Dec. 24 for about $22.3 million. The filing said the sales were made under a Rule 10b5-1 plan adopted on May 21.

A 10b5-1 plan is a pre-set trading program that allows insiders to buy or sell shares on a schedule, helping separate trades from any non-public information that may arise later.

The disclosure comes as investors remain sensitive to CoreWeave’s execution risk and heavy spending profile. In November, the company trimmed its 2025 revenue forecast to $5.05 billion to $5.15 billion after citing a delay at a third-party data center partner, while flagging 2025 capital spending of $12 billion to $14 billion.

Broader market action offered little support for high-growth tech. The S&P 500 and Nasdaq ended slightly lower on Tuesday, while Nvidia slipped 0.4%, and “trading volumes remained thin” in the holiday-shortened week, Reuters reported. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

CoreWeave provides access to high-end graphics processing units (GPUs), chips used to train and run AI models. Nvidia has been a key partner, and CoreWeave has said Nvidia agreed to purchase any unused cloud capacity from CoreWeave through April 2032.

Investors are also tracking how CoreWeave funds its expansion. The company said on Dec. 9 it priced an upsized $2.25 billion private offering of 1.75% convertible senior notes due 2031, a financing that can later convert into equity and dilute shareholders.

What traders are watching next is straightforward: any further insider-sale disclosures, updates on buildouts at data-center partners, and signs that demand from large AI customers is keeping pace with the company’s aggressive investment cycle.

On the tape, Tuesday’s regular-session range of $73.65 to $75.86 left the stock closing near the low end of the day’s band, an area short-term traders often treat as an early support test.

CoreWeave was last at $73.70 after hours, putting the shares down about 1.6% from Monday’s close as the market heads toward the final U.S. trading session of 2025.

Stock Market Today

  • SpaceX IPO Sparks Options Trading Strategy Betting on Tesla Stock Rotation
    June 8, 2026, 8:55 PM EDT. As SpaceX prepares for its initial public offering (IPO) this Friday, traders eye opportunities in related stocks. A popular options trading strategy is betting on a rotation out of Tesla stock, also led by Elon Musk. This move anticipates capital shifting from Tesla shares into the new SpaceX IPO. Investors seek to capitalize on expected volatility and sector rotation within Musk's holdings. The strategy reflects broader market behavior where IPO events influence established stocks linked to the same companies or leadership.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop